logo
logo

Digital Insulin Management Company Hygieia Closes On $17 Million Series B Investment Round

Dec 02, 2021over 3 years ago

Amount Raised

$17 Million

Round Type

series b

Livonia

Description

Hygieia, a digital health company for insulin management, has closed on an initial $17 million Series B investment round, led by Israeli venture capital firm Firstime Ventures, and with participation from existing investors.

Company Information

Company

Hygieia

Location

Livonia, Michigan, United States

About

Hygieia will use the funding to expand partnerships with endocrinology practices and expand access to its unique d-Nav® insulin dose automation technology for people with type 2 diabetes. Currently, Hygieia has two international licenses, in Northern Ireland and in Israel. About Hygieia/ d-Nav Insulin Management ProgramHygieia is a specialty provider of insulin therapy and maker of the d-Nav® Insulin Management Program.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech